(en) « Use of thapsigargin to study Ca2+ homeostasis in cardiac cells », Biosci. Rep., vol. 15, no 5, , p. 341–9 (PMID8825036, DOI10.1007/BF01788366)
(en) Hakii, Fujiki, H., Suganuma, M. et Nakayasu, M., « Thapsigargin, a histamine secretagogue, is a non-12-O-tetradecanolphorbol-13-acetate (TPA) type tumor promoter in two-stage mouse skin carcinogenesis », Journal of Cancer Research and Clinical Oncology, vol. 111, no 3, , p. 177–181 (PMID2426275, DOI10.1007/BF00389230)
(en) H Takemura, A R Hughes, O Thastrup et J W Putney, « Activation of Calcium Entry by the Tumor Promoter Thapsigargin in Parotid Acinar Cells », Journal of Biological Chemistry, vol. 264, no 21, , p. 12266–12271 (ISSN0021-9258, DOI10.1016/s0021-9258(18)63852-9, lire en ligne, consulté le )
(en) T R Jackson, S I Patterson, O Thastrup et M R Hanley, « A novel tumour promoter, thapsigargin, transiently increases cytoplasmic free Ca2+ without generation of inositol phosphates in NG115-401L neuronal cells », Biochemical Journal, vol. 253, no 1, , p. 81–86 (ISSN0264-6021 et 1470-8728, DOI10.1042/bj2530081, lire en ligne, consulté le )
(en) Nhu Thi Quynh Doan, Eleonora Sandholdt Paulsen, Pankaj Sehgal et Jesper Vuust Møller, « Targeting thapsigargin towards tumors », Steroids, sI: Isoprenoids, vol. 97, , p. 2–7 (ISSN0039-128X, DOI10.1016/j.steroids.2014.07.009, lire en ligne, consulté le )
(en) Malhotra et Kaufman, « The endoplasmic reticulum and the unfolded protein response », Seminars in Cell & Developmental Biology, vol. 18, no 6, , p. 716–731 (PMID18023214, PMCID2706143, DOI10.1016/j.semcdb.2007.09.003)
(en) Drew, D.P., Krichau, N., Reichwald, K. et Simonsen, H.T., « Guaianolides in apiaceae: perspectives on pharmacology and biosynthesis », Phytochem Rev., vol. 8, no 3, , p. 581–599 (DOI10.1007/s11101-009-9130-z)
(en) Sundar Neelakantan, Shama Nasim, Monica L. Guzman et Craig T. Jordan, « Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-κB inhibitor, DMAPT (LC-1) », Bioorganic & Medicinal Chemistry Letters, vol. 19, no 15, , p. 4346–4349 (ISSN0960-894X, DOI10.1016/j.bmcl.2009.05.092, lire en ligne, consulté le )
(en) S.Brøgger Christensen et Elsebeth Norup, « Absolute configurations of the histamine liberating sesquiterpene lactones thapsigargin and trilobolide », Tetrahedron Letters, vol. 26, no 1, , p. 107–110 (ISSN0040-4039, DOI10.1016/s0040-4039(00)98480-6, lire en ligne, consulté le )
(en) Stephen P. Andrews, Matthew Ball, Frank Wierschem et Ed Cleator, « Total Synthesis of Five Thapsigargins: Guaianolide Natural Products Exhibiting Sub-Nanomolar SERCA Inhibition », Chemistry - A European Journal, vol. 13, no 20, , p. 5688–5712 (ISSN0947-6539 et 1521-3765, DOI10.1002/chem.200700302, lire en ligne, consulté le )
(en) Samuel R. Denmeade et John T. Isaacs, « The SERCA pump as a therapeutic target: Making a “smart bomb” for prostate cancer », Cancer Biology & Therapy, vol. 4, no 1, , p. 21–29 (ISSN1538-4047, DOI10.4161/cbt.4.1.1505, lire en ligne, consulté le )
(en) Denmeade, Mhaka, Rosen et Brennen, « Engineering a Prostate-Specific Membrane Antigen–Activated Tumor Endothelial Cell Prodrug for Cancer Therapy », Science Translational Medicine, vol. 4, no 140, , p. 140ra86 (PMID22745436, PMCID3715055, DOI10.1126/scitranslmed.3003886)
(en) Ball, Andrews, Wierschem et Cleator, « Total Synthesis of Thapsigargin, a Potent SERCA Pump Inhibitor », Organic Letters, vol. 9, no 4, , p. 663–6 (PMID17256950, DOI10.1021/ol062947x)
(en) Chen et Evans, « A Concise, Efficient and Scalable Total Synthesis of Thapsigargin and Nortrilobolide from (R)-(-)-Carvone », J. Am. Chem. Soc., vol. 139, no 17, , p. 6046–6049 (PMID28422492, DOI10.1021/jacs.7b01734)
(en) Glushakov, Glushakova et Skok, « Modulation of nicotinic acetylcholine receptor activity in submucous neurons by intracellular messengers », Journal of the Autonomic Nervous System, vol. 75, no 1, , p. 16–22 (ISSN0165-1838, PMID9935265, DOI10.1016/S0165-1838(98)00165-9)
(en) Voitenko, Bobryshev et Skok, « Intracellular regulation of neuronal nicotinic cholinorceptors », Neuroscience and Behavioral Physiology, vol. 30, no 1, , p. 19–25 (ISSN0097-0549, PMID10768368, DOI10.1007/BF02461388)
doi.org
(en) Samuel R. Denmeade et John T. Isaacs, « The SERCA pump as a therapeutic target: Making a “smart bomb” for prostate cancer », Cancer Biology & Therapy, vol. 4, no 1, , p. 21–29 (ISSN1538-4047, DOI10.4161/cbt.4.1.1505, lire en ligne, consulté le )
(en) H Takemura, A R Hughes, O Thastrup et J W Putney, « Activation of Calcium Entry by the Tumor Promoter Thapsigargin in Parotid Acinar Cells », Journal of Biological Chemistry, vol. 264, no 21, , p. 12266–12271 (ISSN0021-9258, DOI10.1016/s0021-9258(18)63852-9, lire en ligne, consulté le )
(en) T R Jackson, S I Patterson, O Thastrup et M R Hanley, « A novel tumour promoter, thapsigargin, transiently increases cytoplasmic free Ca2+ without generation of inositol phosphates in NG115-401L neuronal cells », Biochemical Journal, vol. 253, no 1, , p. 81–86 (ISSN0264-6021 et 1470-8728, DOI10.1042/bj2530081, lire en ligne, consulté le )
(en) Nhu Thi Quynh Doan, Eleonora Sandholdt Paulsen, Pankaj Sehgal et Jesper Vuust Møller, « Targeting thapsigargin towards tumors », Steroids, sI: Isoprenoids, vol. 97, , p. 2–7 (ISSN0039-128X, DOI10.1016/j.steroids.2014.07.009, lire en ligne, consulté le )
(en) Engedal, Torgersen, Guldvik et Barfeld, « Modulation of intracellular calcium homeostasis blocks autophagosome formation », Autophagy, vol. 9, no 10, , p. 1475–1490 (ISSN1554-8627, PMID23970164, DOI10.4161/auto.25900)
(en) Sundar Neelakantan, Shama Nasim, Monica L. Guzman et Craig T. Jordan, « Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-κB inhibitor, DMAPT (LC-1) », Bioorganic & Medicinal Chemistry Letters, vol. 19, no 15, , p. 4346–4349 (ISSN0960-894X, DOI10.1016/j.bmcl.2009.05.092, lire en ligne, consulté le )
(en) S.Brøgger Christensen et Elsebeth Norup, « Absolute configurations of the histamine liberating sesquiterpene lactones thapsigargin and trilobolide », Tetrahedron Letters, vol. 26, no 1, , p. 107–110 (ISSN0040-4039, DOI10.1016/s0040-4039(00)98480-6, lire en ligne, consulté le )
(en) Stephen P. Andrews, Matthew Ball, Frank Wierschem et Ed Cleator, « Total Synthesis of Five Thapsigargins: Guaianolide Natural Products Exhibiting Sub-Nanomolar SERCA Inhibition », Chemistry - A European Journal, vol. 13, no 20, , p. 5688–5712 (ISSN0947-6539 et 1521-3765, DOI10.1002/chem.200700302, lire en ligne, consulté le )
(en) Samuel R. Denmeade et John T. Isaacs, « The SERCA pump as a therapeutic target: Making a “smart bomb” for prostate cancer », Cancer Biology & Therapy, vol. 4, no 1, , p. 21–29 (ISSN1538-4047, DOI10.4161/cbt.4.1.1505, lire en ligne, consulté le )
(en) Glushakov, Glushakova et Skok, « Modulation of nicotinic acetylcholine receptor activity in submucous neurons by intracellular messengers », Journal of the Autonomic Nervous System, vol. 75, no 1, , p. 16–22 (ISSN0165-1838, PMID9935265, DOI10.1016/S0165-1838(98)00165-9)
(en) Voitenko, Bobryshev et Skok, « Intracellular regulation of neuronal nicotinic cholinorceptors », Neuroscience and Behavioral Physiology, vol. 30, no 1, , p. 19–25 (ISSN0097-0549, PMID10768368, DOI10.1007/BF02461388)
(en) Rasmussen U, Brøogger Christensen S, Sandberg F, « Thapsigargine and thapsigargicine, two new histamine liberators from Thapsia garganica L. », Acta Pharm. Suec., vol. 15, no 2, , p. 133–140 (PMID79299)
(en) « Use of thapsigargin to study Ca2+ homeostasis in cardiac cells », Biosci. Rep., vol. 15, no 5, , p. 341–9 (PMID8825036, DOI10.1007/BF01788366)
(en) Hakii, Fujiki, H., Suganuma, M. et Nakayasu, M., « Thapsigargin, a histamine secretagogue, is a non-12-O-tetradecanolphorbol-13-acetate (TPA) type tumor promoter in two-stage mouse skin carcinogenesis », Journal of Cancer Research and Clinical Oncology, vol. 111, no 3, , p. 177–181 (PMID2426275, DOI10.1007/BF00389230)
(en) Malhotra et Kaufman, « The endoplasmic reticulum and the unfolded protein response », Seminars in Cell & Developmental Biology, vol. 18, no 6, , p. 716–731 (PMID18023214, PMCID2706143, DOI10.1016/j.semcdb.2007.09.003)
(en) Ball, Andrews, Wierschem et Cleator, « Total Synthesis of Thapsigargin, a Potent SERCA Pump Inhibitor », Organic Letters, vol. 9, no 4, , p. 663–6 (PMID17256950, DOI10.1021/ol062947x)
(en) Chen et Evans, « A Concise, Efficient and Scalable Total Synthesis of Thapsigargin and Nortrilobolide from (R)-(-)-Carvone », J. Am. Chem. Soc., vol. 139, no 17, , p. 6046–6049 (PMID28422492, DOI10.1021/jacs.7b01734)
(en) Glushakov, Glushakova et Skok, « Modulation of nicotinic acetylcholine receptor activity in submucous neurons by intracellular messengers », Journal of the Autonomic Nervous System, vol. 75, no 1, , p. 16–22 (ISSN0165-1838, PMID9935265, DOI10.1016/S0165-1838(98)00165-9)
(en) Voitenko, Bobryshev et Skok, « Intracellular regulation of neuronal nicotinic cholinorceptors », Neuroscience and Behavioral Physiology, vol. 30, no 1, , p. 19–25 (ISSN0097-0549, PMID10768368, DOI10.1007/BF02461388)